The annual Regulatory Convergence, hosted by the Regulatory Affairs Professionals Society (RAPS), will convene 24–28 October at the Baltimore Convention Center. The event is the largest annual gathering of the global healthcare regulatory community, including healthcare product regulators, scientists, innovators, and regulatory professionals from life sciences companies of all sizes. This year’s conference will feature keynote remarks from Acting Commissioner of the US Food and Drug Administration (FDA) Stephen Ostroff; and best-selling author and TV host Daniel Pink.
“Regulation of healthcare products like pharmaceutical drugs, medical devices and biotechnology products impacts all of our lives in so many ways, and regulatory professionals play key roles,” said RAPS Executive Director Sherry Keramidas, PhD, FASAE, CAE. “The Regulatory Convergence is an opportunity to come together as a profession and examine important regulatory issues in depth.”
The conference will feature more than 75 different sessions covering biopharmaceuticals, medical devices, health-related foods, and legal and business issues. More than 300 speakers will present, including officials from at least 22 global agencies and organizations, including:
- the European Medicines Agency (EMA)
- the China Food and Drug Administration (CFDA)
- the World Health Organization (WHO)
- the Pan American Health Organization (PAHO)
- the Brazilian Health Surveillance Agency (ANVISA)
- Pharmaceuticals and Medical Devices Agency, Japan (PMDA)
For the full conference schedule, visit here. Follow conference updates and conversations on Twitter using the #2015RAPS hashtag.